Henrik Jessen Jürgensen

Henrik Jessen Jürgensen is a Researcher at the Biotech Research & Innovation Centre (BRIC) at the University of Copenhagen, working within the Behrendt Group. His research focuses on cancer biology, particularly examining receptor systems involved in tumor progression and the tumor microenvironment.

Dr. Jürgensen's research interests center on extracellular matrix biology, receptor-mediated processes, and their roles in cancer development. His work particularly investigates the uPAR system and collagen receptors like uPARAP/Endo180, exploring their functions in tumor growth, metastasis, and immune regulation. His research spans molecular mechanisms to potential therapeutic applications, with a strong emphasis on translational approaches to cancer treatment.

Analysis of his recent publications reveals a consistent focus on receptor biology in cancer contexts, particularly examining how endocytic receptors influence tumor microenvironments, collagen degradation, and immune responses. His work demonstrates strong interdisciplinary collaboration across molecular biology, cancer research, and structural biology.

Dr. Jürgensen has been involved in research that has garnered significant attention, with publications referenced in patents, picked up by news outlets, and widely read by scientific communities as evidenced by Mendeley reader statistics.